The associations between central serous chorioretinopathy and muscle relaxants: A case–control study

PURPOSE: To evaluate the role of muscle-relaxants as risk factors for the development of central serous chorioretinopathy (CSC) - the second most common retinopathy in our settings; despite multiple risk factors seen in our patients, 21% were initially labelled as idiopathic. MATERIALS AND METHODS:...

Full description

Bibliographic Details
Main Authors: Manish Jain, Sunir J Garg, Mohammad Khan, Varun Chaudhary, Dena Zeraatkar, Dhanya Kurian, Sarath Lal
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2022-01-01
Series:Taiwan Journal of Ophthalmology
Subjects:
Online Access:http://www.e-tjo.org/article.asp?issn=2211-5056;year=2022;volume=12;issue=4;spage=415;epage=422;aulast=Jain
_version_ 1811200239750610944
author Manish Jain
Sunir J Garg
Mohammad Khan
Varun Chaudhary
Dena Zeraatkar
Dhanya Kurian
Sarath Lal
author_facet Manish Jain
Sunir J Garg
Mohammad Khan
Varun Chaudhary
Dena Zeraatkar
Dhanya Kurian
Sarath Lal
author_sort Manish Jain
collection DOAJ
description PURPOSE: To evaluate the role of muscle-relaxants as risk factors for the development of central serous chorioretinopathy (CSC) - the second most common retinopathy in our settings; despite multiple risk factors seen in our patients, 21% were initially labelled as idiopathic. MATERIALS AND METHODS: Retrospective case-control study at a tertiary hospital in the United Arab Emirates, where we reviewed the medical records of 273 patients with CSC examined between 2010 and 2019 for use of muscle-relaxants including tolperisone/eperisone, carisoprodol and gabapentin/pregabalin within a year of onset/recurrence of the disease. Intake of drugs with known association with CSC (including corticosteroids/sympathomimetics) was also recorded. Two hundred eighty-six subjects with adverse events seen at the same institute during the same study period served as controls. Odds ratios, Chi-Square tests and multivariate logistic regression were carried out to determine any associations with the muscle-relaxants and other pharmacological confounders - corticosteroids/sympathomimetics. RESULTS: Muscle relaxants may increase the risk of CSC as evident on multivariate regression analysis (OR: 2.55; confidence interval [CI]: 1.208-5.413); the significance was retained on removing the 6 subjects who had corticosteroids/sympathomimetics (OR: 2.30; CI: 1.073–4.939). Univariate analysis yielded an OR of 2.52 for muscle relaxants (CI: 1.2149–5.2276), 2.96 for eperisone/tolperisone (CI: 1.3531–6.5038), and 6.26 for eperisone as an individual agent (CI: 1.8146–21.6252). CONCLUSION: We found muscle relaxants to be associated factors of CSC regardless of inclusion of corticosteroids/sympathomimetics (P < 0.05). Among individual classes of muscle relaxants in this study, only eperisone/tolperisone posed a significant risk (P < 0.05). The vascular smooth muscle relaxation could be the possible mechanism that affects the choroidal blood flow and indirectly predisposes to CSC.
first_indexed 2024-04-12T02:01:13Z
format Article
id doaj.art-5b5b43a9a4bd46169a0cba73cfed681c
institution Directory Open Access Journal
issn 2211-5056
2211-5072
language English
last_indexed 2024-04-12T02:01:13Z
publishDate 2022-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Taiwan Journal of Ophthalmology
spelling doaj.art-5b5b43a9a4bd46169a0cba73cfed681c2022-12-22T03:52:40ZengWolters Kluwer Medknow PublicationsTaiwan Journal of Ophthalmology2211-50562211-50722022-01-0112441542210.4103/2211-5056.361975The associations between central serous chorioretinopathy and muscle relaxants: A case–control studyManish JainSunir J GargMohammad KhanVarun ChaudharyDena ZeraatkarDhanya KurianSarath LalPURPOSE: To evaluate the role of muscle-relaxants as risk factors for the development of central serous chorioretinopathy (CSC) - the second most common retinopathy in our settings; despite multiple risk factors seen in our patients, 21% were initially labelled as idiopathic. MATERIALS AND METHODS: Retrospective case-control study at a tertiary hospital in the United Arab Emirates, where we reviewed the medical records of 273 patients with CSC examined between 2010 and 2019 for use of muscle-relaxants including tolperisone/eperisone, carisoprodol and gabapentin/pregabalin within a year of onset/recurrence of the disease. Intake of drugs with known association with CSC (including corticosteroids/sympathomimetics) was also recorded. Two hundred eighty-six subjects with adverse events seen at the same institute during the same study period served as controls. Odds ratios, Chi-Square tests and multivariate logistic regression were carried out to determine any associations with the muscle-relaxants and other pharmacological confounders - corticosteroids/sympathomimetics. RESULTS: Muscle relaxants may increase the risk of CSC as evident on multivariate regression analysis (OR: 2.55; confidence interval [CI]: 1.208-5.413); the significance was retained on removing the 6 subjects who had corticosteroids/sympathomimetics (OR: 2.30; CI: 1.073–4.939). Univariate analysis yielded an OR of 2.52 for muscle relaxants (CI: 1.2149–5.2276), 2.96 for eperisone/tolperisone (CI: 1.3531–6.5038), and 6.26 for eperisone as an individual agent (CI: 1.8146–21.6252). CONCLUSION: We found muscle relaxants to be associated factors of CSC regardless of inclusion of corticosteroids/sympathomimetics (P < 0.05). Among individual classes of muscle relaxants in this study, only eperisone/tolperisone posed a significant risk (P < 0.05). The vascular smooth muscle relaxation could be the possible mechanism that affects the choroidal blood flow and indirectly predisposes to CSC.http://www.e-tjo.org/article.asp?issn=2211-5056;year=2022;volume=12;issue=4;spage=415;epage=422;aulast=Jaincarisoprodolcentral serous chorioretinopathyeperisonegabapentinmuscle relaxantspregabalintolperisone
spellingShingle Manish Jain
Sunir J Garg
Mohammad Khan
Varun Chaudhary
Dena Zeraatkar
Dhanya Kurian
Sarath Lal
The associations between central serous chorioretinopathy and muscle relaxants: A case–control study
Taiwan Journal of Ophthalmology
carisoprodol
central serous chorioretinopathy
eperisone
gabapentin
muscle relaxants
pregabalin
tolperisone
title The associations between central serous chorioretinopathy and muscle relaxants: A case–control study
title_full The associations between central serous chorioretinopathy and muscle relaxants: A case–control study
title_fullStr The associations between central serous chorioretinopathy and muscle relaxants: A case–control study
title_full_unstemmed The associations between central serous chorioretinopathy and muscle relaxants: A case–control study
title_short The associations between central serous chorioretinopathy and muscle relaxants: A case–control study
title_sort associations between central serous chorioretinopathy and muscle relaxants a case control study
topic carisoprodol
central serous chorioretinopathy
eperisone
gabapentin
muscle relaxants
pregabalin
tolperisone
url http://www.e-tjo.org/article.asp?issn=2211-5056;year=2022;volume=12;issue=4;spage=415;epage=422;aulast=Jain
work_keys_str_mv AT manishjain theassociationsbetweencentralserouschorioretinopathyandmusclerelaxantsacasecontrolstudy
AT sunirjgarg theassociationsbetweencentralserouschorioretinopathyandmusclerelaxantsacasecontrolstudy
AT mohammadkhan theassociationsbetweencentralserouschorioretinopathyandmusclerelaxantsacasecontrolstudy
AT varunchaudhary theassociationsbetweencentralserouschorioretinopathyandmusclerelaxantsacasecontrolstudy
AT denazeraatkar theassociationsbetweencentralserouschorioretinopathyandmusclerelaxantsacasecontrolstudy
AT dhanyakurian theassociationsbetweencentralserouschorioretinopathyandmusclerelaxantsacasecontrolstudy
AT sarathlal theassociationsbetweencentralserouschorioretinopathyandmusclerelaxantsacasecontrolstudy
AT manishjain associationsbetweencentralserouschorioretinopathyandmusclerelaxantsacasecontrolstudy
AT sunirjgarg associationsbetweencentralserouschorioretinopathyandmusclerelaxantsacasecontrolstudy
AT mohammadkhan associationsbetweencentralserouschorioretinopathyandmusclerelaxantsacasecontrolstudy
AT varunchaudhary associationsbetweencentralserouschorioretinopathyandmusclerelaxantsacasecontrolstudy
AT denazeraatkar associationsbetweencentralserouschorioretinopathyandmusclerelaxantsacasecontrolstudy
AT dhanyakurian associationsbetweencentralserouschorioretinopathyandmusclerelaxantsacasecontrolstudy
AT sarathlal associationsbetweencentralserouschorioretinopathyandmusclerelaxantsacasecontrolstudy